360 Financial, Inc. Pfizer Inc Transaction History

360 Financial, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$43.76 - $53.42 $20,567 - $25,107	470 Added 10.96%	4,760 $208,000
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $21,869 - $25,929	-470 Reduced 9.87%	4,290 $220,000
Q1 2022 Apr 11, 2022	SELL	$45.75 - $56.69 $4,575 - $5,669	-100 Reduced 2.06%	4,760 $242,000
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $4,132 - $6,125	-100 Reduced 2.02%	4,860 $287,000
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $194,680 - $250,083	4,960 New	4,960 $213,000

3,257

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of 360 Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on 360 Financial, Inc. with notifications on news.